MOEXA

Pharmaceutical preparations for the treatment and prevention of cancer and fibrosis; Pharmaceutical preparations for medical purposes; Medical preparations for the treatment of cancer and fibrosis; Veterinary pharmaceutical preparations for the treatment of cancer and fibrosis; Medicaments for the treatment and prevention of cancer and fibrosis; Anti-cancer preparations; Medicaments for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for preparations of therapeutic compounds for treatment, inhibition or prevention of cell proliferation, preparations and medicaments for therapeutic compounds for treatment, inhibition or prevention of cancer and fibrosis; Veterinary pharmaceutical preparations for the prevention of cancer and fibrosis; Pharmaceutical preparations for the prevention of cell proliferation; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the prevention of fibrosis; Medicaments for the prevention of fibrosis; Dietetic foods adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic pet foods adapted for veterinary use; Dietetic pet foods adapted for veterinary purposes; Dietary supplements for humans and animals; Pharmaceutical preparations for preparation of therapeutic compounds for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for preparation of therapeutic compounds for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for the prevention of cell proliferation; Medicaments for the prevention of cancer